Welcome to the Study Portal!
Current Breast Cancer Studies
Studies Improve Chances
In addition to common treatment methods with approved drugs and guideline-based therapy concepts, patients have the opportunity to participate in clinical studies. Clinical studies are absolutely necessary to achieve progress in cancer treatment. They are also essential for developing the best and most effective therapy strategies for patients.
Participation in clinical studies can be beneficial (quality feature & prognostic factor). In your individual case, please discuss current studies with your treating physician!
Goals of the Breast Cancer Portal
This portal offers comprehensive information on the goals, procedures, and conditions of current studies and surveys, and lists where these studies are conducted near you by study centers, clinics, or practices. In addition, we have compiled the most important facts about breast cancer and its therapy for you and are continuously expanding the information available to enable you to make well-informed decisions.
Organized by the Forum Gyn Oncology, the new study portal focusing on breast cancer studies was created. We launched this portal together with the initiators Prof. Dr. Jens-Uwe Blohmer (Charité Berlin) and Prof. Dr. med. Sherko Kümmel (Kliniken Essen-Mitte) as an innovative information portal for people with breast cancer.
Prof. Dr. med. Jens-Uwe Blohmer
Director of the Clinic for Gynecology with Breast Center at Charité, Campus Mitte
Prof. Dr. med. Maggie Banys-Paluchowski
Senior Physician and Head of the Breast Center at the Clinic for Gynecology and Obstetrics UKSH, Campus Lübeck
Partners of the Breast Cancer Study Portal
Cooperation Partners
Supporters of the Breast Cancer Study Portal
Professional and Transparent
The German Ovarian Cancer Foundation works together with the supporters of the study portal to improve studies and surveys. This is not possible without the high-quality and professional research work of the study centers as well as the researching pharmaceutical industry. We, the German Ovarian Cancer Foundation, and on behalf of the GYN Study Portal, would like to thank the supporters at this point.
